Related Experiment Video
Updated: Jun 24, 2026

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice
Published on: September 2, 2020
Pharmacology of vanilloid transient receptor potential cation channels
Joris Vriens1, Giovanni Appendino, Bernd Nilius
1Department of Molecular Cell Biology, Katholieke Universiteit Leuven, Belgium.
Abstract:
Depending on their primary structure, the 28 mammalian transient receptor potential (TRP) cation channels identified so far can be sorted into 6 subfamilies: TRPC ("Canonical"), TRPV ("Vanilloid"), TRPM ("Melastatin"), TRPP ("Polycystin"), TRPML ("Mucolipin"), and TRPA ("Ankyrin"). The TRPV subfamily (vanilloid receptors) comprises channels critically involved in nociception and thermosensing (TRPV1, TRPV2, TRPV3, and TRPV4), whereas TRPV5 and TRPV6 are involved in renal Ca(2+) absorption/reabsorption. Apart from TRPV1, the pharmacology of these channels is still insufficiently known. Furthermore, only few small-molecule ligands for non-TRPV1 vanilloid receptors have been identified, and little is known of their endogenous ligands, resulting in a substantial "orphan" state for these channels. In this review, we summarize the pharmacological properties of members of the TRPV subfamily, highlighting the critical issues and challenges facing their "deorphanization" and clinical exploitation.
Insights
This review explores the pharmacology of Transient Receptor Potential Vanilloid (TRPV) channels. It highlights challenges in understanding these channels and their potential for clinical use.
Area of Science:
- Physiology
- Pharmacology
- Molecular Biology
Background:
- Mammalian Transient Receptor Potential (TRP) channels comprise 6 subfamilies, including TRPV (vanilloid receptors).
- The TRPV subfamily is crucial for nociception, thermosensing (TRPV1-4), and renal calcium handling (TRPV5-6).
- The pharmacology of most TRPV channels, beyond TRPV1, remains largely unknown, with few identified ligands.
Purpose of the Study:
- To review the pharmacological properties of the TRPV subfamily.
- To highlight the challenges in deorphanizing non-TRPV1 vanilloid receptors.
- To discuss the potential for clinical exploitation of TRPV channels.
Main Methods:
- Literature review of existing research on TRPV channel pharmacology.
- Analysis of identified small-molecule and endogenous ligands for TRPV channels.
- Discussion of current challenges and future directions in TRPV research.
Main Results:
- TRPV1 is well-characterized pharmacologically, unlike other TRPV members.
- A significant number of TRPV channels remain 'orphan,' lacking known ligands.
- Limited small-molecule and endogenous ligands have been identified for non-TRPV1 vanilloid receptors.
Conclusions:
- Further research is needed to elucidate the pharmacology of the TRPV subfamily.
- Deorphanizing TRPV channels is critical for understanding their physiological roles.
- Successful deorphanization could lead to novel therapeutic strategies.
More Related Videos
12:09Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
Published on: December 31, 2013
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Mechanically-gated Ion Channels
Mechanically-gated Ion Channels
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.